Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts, United States
Caron A. Jacobson, MD, MMSc, is an oncolgist who specializes in lymphoma at the Dana-Farber Cancer Institute. She does clinical and translational research in lymphoma and in CAR T-cell therapy and is the medical director of the Immune Effector Cell Therapy Program at DFCI, which oversees both the commercial CAR T-cell programs in lymphoma and leukemia, as well as the research programs in all engineered cell therapies, which span multiple different disease centers.
Session VIII: Indolent Lymphomas and CAR-T Cells
Thursday, October 19, 2023
4:00 PM – 5:35 PM ET
Thursday, October 19, 2023
4:25 PM – 4:40 PM ET
CAR-T cells – What does the Future Hold? Are all CAR-Ts Comparable?
Thursday, October 19, 2023
4:55 PM – 5:15 PM ET
Panel Discussion and Post-Session Audience Survey
Thursday, October 19, 2023
5:15 PM – 5:35 PM ET